Specifically, using co-culture models of patient autologous pDC–T–NK–MM cells, authors showed that pharmacological blockade of KMO activates pDCs and triggers both MM-specific cytotoxic T-cell lymphocytes (CTL) and NK cells` cytolytic activity against tumor cells. The gene discussed is KMO; the disease is Miyoshi myopathy.